The Brighterside of News on MSN
New study provides a key breakthrough in cancer therapy and synthetic biology
Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.
A newly revealed molecular tug-of-war may have implications for better understanding how a multitude of diseases and disorders—including cancers, neurodegenerative diseases and immune ...
Creating mini mitochondria factories helped recharge damaged cells in a dish, providing proof-of-concept work that could pave ...
Acute myeloid leukemia (AML) cells under the microscope, in purple. There is a serious need for finding better ways to treat AML that comes back after initial treatment. Chimeric antigen receptor (CAR ...
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...
A new study has revealed that a special group of cells in the intestines tamp down the immune responses caused by exposure to food proteins. Called 'tolerogenic dendritic cells,' these cells enable ...
Small cell lung cancer, or SCLC, is aggressive, lethal and particularly cruel because chemotherapy initially works so well. But within just a few months, SCLC becomes resistant to drugs and dashes ...
During infections, the immune system needs to distinguish foreign antigens that are expressed by invading bacteria and viruses from self-antigens that are expressed by cells of the body. If not, the ...
Scientists have discovered that our specialized immune cells, called T cells, are what they eat -- their switch from functional to 'exhausted' depends on the switch from metabolizing acetate to ...
Declining immune responsiveness with age may be driven by changes in immune cells — not by inflammation, as previously thought. When you purchase through links on our site, we may earn an affiliate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results